Free CME from PeerView

Free Online and Live CME/MOC/CNE/CPE

Recently Published Activities

Credits: 1.0 CME / MOC / NCPD

Penn State College of Medicine

Mapping the Therapeutic Odyssey in Multiple Myeloma: Interprofessional Guidance on Evidence-Based Treatment Selection and Sequencing

Nina Shah, MD

May 09, 2022

Credits: 1.0 CME / MOC / CPE

Medical Learning Institute, Inc.

Making Sense of the Evolving Treatment Landscape in Ovarian Cancer Care: Pharmacy Perspectives on PARP Inhibitor Therapy

Thomasina Morris, RPh, MHA, BCOP

May 06, 2022

Credits: 0.25 CME / CPE

Medical Learning Institute, Inc.

Making Sense of New Standards for CLL: Pharmacist Insights on Targeted Therapy and the Delivery of Team-Based Care

Amber C. King, PharmD, BCOP

May 06, 2022

Credits: 1.0 CME / MOC / CC / NCPD / CPE

Medical Learning Institute, Inc.

How to Harness Adjuvant CDK4 and 6 Inhibition to Prevent Recurrences in High-Risk HR+/HER2- Early Breast Cancer: New Goals and Better Tools to Close the Gaps

Erika Hamilton, MD

April 29, 2022

Credits: 1.0 CME / MOC / NCPD / CPE

PVI, PeerView Institute for Medical Education

Weighing the Evidence, Parsing the Practicalities: Integrating New Treatment Options Into the SCLC Treatment Arsenal to Improve Patient Outcomes in Oncology Practice

Jacob Sands, MD

April 27, 2022

Credits: 0.5 CME / MOC

PVI, PeerView Institute for Medical Education

Cancer Control Through Early Blood-Based Detection: Perspectives on Integrating Innovative Multicancer Early Detection Tests in the Primary Care Setting

John J. Russell, MD

April 22, 2022

Credits: 1.0 CME

PVI, PeerView Institute for Medical Education

Expanding Options, Lingering Questions: How to Select the Right Immunotherapy for First-Line Treatment of Advanced NSCLC

Mark A. Socinski, MD

April 20, 2022

Credits: 1.25 CME

Medical Learning Institute, Inc.

Expanding the Benefits of PARP Inhibitor Therapy to More Patients With Breast Cancer and Earlier Disease Settings: Multidisciplinary Perspectives on How to Maximize the Potential of PARP Inhibitors and Optimize Their Use as Part of Multimodal Management o

Henry M. Kuerer, MD, PhD, FACS

April 08, 2022

Credits: 0.5 CME / MOC / NCPD / CPE

PVI, PeerView Institute for Medical Education

Dialing in the Dose: Reviewing Recent Evidence and Team-Based Strategies to Personalize and Optimize Patient Care in Metastatic Colorectal Cancer

Tanios Bekaii-Saab, MD

April 07, 2022

Credits: 0.5 CME / MOC / NCPD

Medical Learning Institute, Inc.

Solving the Challenge of Tumor Lysis Syndrome: Expert Insight and Guidance on a Challenging Oncologic Emergency

Anthony R. Mato, MD, MSCE

April 04, 2022